^
Association details:
Evidence:
Evidence Level:
Sensitive: B - Late Trials
Title:

TERT copy gain predicts the outcome of high-dose interferon a-2b therapy in acral melanoma

Published date:
07/17/2018
Excerpt:
...However, among the 278 patients who received an HD-IFN regimen, Kaplan-Meier survival analysis demonstrated a significant correlation between TERT copy gain and relapse-free survival (RFS) (P=0.008)...
DOI:
10.2147/OTT.S158239